Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival-Reference-Cited by-同舟云学术

Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival

Published:2017-02-02 Issue:1 Volume:9 Page:
ISSN:1868-7075
Container-title:Clinical Epigenetics
language:en
Short-container-title:Clin Epigenet

Author:

Wiencke John K.,Koestler Devin C.,Salas Lucas A.,Wiemels Joseph L.,Roy Ritu P.,Hansen Helen M.,Rice Terri,McCoy Lucie S.,Bracci Paige M.,Molinaro Annette M.,Kelsey Karl T.,Wrensch Margaret R.,Christensen Brock C.

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Developmental Biology,Genetics,Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13148-017-0316-8.pdf

Reference43 articles.

1. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol. 2012;14 Suppl 5:v1–49.

2. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.

3. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.

4. Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med. 2015;372:2499–508.

5. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune cell markers associated with early life major depressive episodes;Journal of Mood & Anxiety Disorders;2024-06

2. Immunomethylomic profiles of long-term head and neck squamous cell carcinoma survivors on immune checkpoint inhibitors;Epigenomics;2024-05-17

3. Systemic and local immunosuppression in glioblastoma and its prognostic significance;Frontiers in Immunology;2024-02-28

4. Glioma–Immune Cell Crosstalk in Tumor Progression;Cancers;2024-01-11

5. Matched Analysis of Detailed Peripheral Blood and Tumor Immune Microenvironment Profiles in Bladder Cancer;Epigenomics;2024-01